Publications

Year of Publication Titlesort descending Faculty Association
2019 Animal Models for the Study of Bone-Derived Pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2017 Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. Jeffrey J. Lochhead, PhD
2014 Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling. Nam Lee, Ph.D.
2006 AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.
2022 Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer's Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients. Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D.
2015 Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. Roberta Diaz Brinton, Ph.D
2005 Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Jeffrey J. Lochhead, PhD
2005 Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. Jeffrey J. Lochhead, PhD
2014 Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. John M. Streicher, PhD
2016 Biphalin: The Foundation of Bivalent Ligands.
2015 Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors. Frank Porreca, PhD, Todd Vanderah, PhD
2017 Blocking CRMP2 SUMOylation reverses neuropathic pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2018 Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Patrick T Ronaldson, PhD, FAAPS
2022 Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2017 Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2016 Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. Roberta Diaz Brinton, Ph.D
2019 Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions Christopher Cartmell
2019 Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions. Christopher Cartmell
2013 Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. Peg Davis, Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2013 Cancer-induced bone pain: Mechanisms and models. Todd Vanderah, PhD
2020 Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2014 Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in rats. Tally Largent-Milnes, PhD
2019 Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2001 cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.
2022 Cerebral arteriolar and neurovascular dysfunction after chemically induced menopause in mice. Tally Largent-Milnes, PhD

Pages